My research interests focus on the roles mitochondria play in aspects of eukaryotic life, ranging from their origin, metabolism, biogenesis and role they play in cell death pathways. These are interrogated using biochemical, molecular biology, genetic and cell biology techniques. I incorporate these interests into classes I teach to provide an understanding of practical techniques and also the current literature in the field. I studied biochemistry at the University of Leeds, with an industrial placement at Astra Charnwood, followed by a PhD at the University of Bristol, supervised by Professor Andrew Halestrap, to characterise the molecular composition of the mitochondrial permeability transition pore, with support from MitoKor. My post-doctoral training on the mitochondrial pathway of apoptosis supervised by Dr Doug Green was at the La Jolla Institute of Allergy and Immunology in San Diego, California and St Jude Children's Research Hospital in Memphis, Tennessee. I then was an associate research scientist working in the laboratory of Professor Alexander Tzagoloff at Columbia University in New York to study biogenesis of mitochondrial cytochrome c oxidase in budding yeast, Saccharomyces cerevisiae. I held independent positions as assistant professor at the New York Institute of Technology in New York and Staffordshire University in Stoke-on-Trent where I continued my research and taught subjects related to biochemistry, cell biology, genetics and molecular biology. I am now a senior lecturer in biotechnology at Liverpool John Moores University.  I am a strong supporter of scientific communications and outreach to disseminate scientific developments and knowledge to a broader audience with the goal of increasing the general support of the scientific process. I also direct Biomed News, a free biomedical research literature discovery platform that uses machine learning.

Here: https://albruzos.github.io/about/

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. His research aims to improve the life expectancy of sea animals and humans. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer patients in South Korea and Sweden. Additionally, he collaborates with researchers from India, Taiwan, Israel, US, Denmark, Singapore, Spain, Portugal, and the United Kingdom on various collaborative projects.

Initially funded by the European Commission’s Horizon 2020 programme, the first four ENABLE conferences were held in the cities hosting the headquarters of the four entities leading the project: the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona, Spain; the Radboud Institute for Molecular Life Sciences (RIMLS) in Nijmegen, The Netherlands; The Novo Nordisk Foundation Center for Protein Research (CPR) in Copenhagen, Denmark; and the Scuola Europea di Medicina Molecolare (SEMM), in Milan, Italy. In this new cycle of conferences, FEBS, IUBMB and the four core ENABLE institutions have joined forces to share ENABLE best practices with other international research institutions. To this end, in addition to the four core research centres, other institutions can apply to become associated centres and host one of the events. For the 2024 event, FEBS-IUBMB-ENABLE will actively search for an associated centre in a non-European country to ensure that one of the events is held on another continent.

As a Senior Lecturer in Biomedical Science, I teach across several modules on the BSc (Hons) Biomedical Science programme. My research aims to uncover the mechanisms that protect the genetic integrity of both nuclear and mitochondrial DNA. 

Dr. Cristina Blanco Sío-López is Marie Skłodowska-Curie Senior Global Fellow and Principal Investigator (PI) of the EU Horizon 2020 research project ‘Navigating Schengen: Historical Challenges and Potentialities of the EU’s Free Movement of Persons, 1985-2015’ (NAVSCHEN) at the European Studies Center (ESC) – EU Jean Monnet European Centre of Excellence (JMEUCE) of the University of Pittsburgh (2019-2021) and at the Ca' Foscari University of Venice. She previously was Assistant Professor in European Culture and Politics at the University of Groningen and ‘Santander’ Senior Fellow in Iberian and European Studies at the European Studies Centre (ESC) – St. Antony’s College of the University of Oxford, where she remains a Senior Member.  She is Executive Committee Member of the Global Young Academy (GYA), Fellow of the Young Academy of Europe (YAE) and Full Member of the Young Academy of Spain. She was Chair of the North America Chapter of the Marie Curie Alumni Association (MCAA) in 2020-2021, which received the ‘Best Non-European Chapter Award 2020’ by the MCAA.  She obtained her PhD in History and Civilization (European Integration History) at the European University Institute of Florence (EUI) and received the FAEY Best PhD Thesis ‘European Research and Mobility’ Award in 2008.

James Perkins is a postdoctoral bioinformatics and computational biology researcher at the University of Malaga-IBIMA and the Spanish Rare Disease Biomedical Research Network (CIBERER). His research interests include omics-analysis, target prioritization, functional annotation, systems biology and disease-phenotype analysis, with a focus on rare disease.